Neva is pleased to unveil further opportunities as a true collaborator for early-stage pharma/biotech innovators.

As the pharmaceutical industry continues to evolve in the wake of pandemic-driven disruptions and heightened regulatory scrutiny, the role of the top pharmaceutical API manufacturer has taken on ...

Biotech company BioMarin Pharmaceutical (NASDAQ:BMRN) reported Q4 CY2025 results , with sales up 17% year on year to $874.6 ...

AI is rewriting biotech’s commercial playbook—cutting waste, shrinking teams, and giving first‑time drugmakers a faster, ...

The third quarter was a pivotal period for both the biotech and pharmaceutical sectors, with regulatory developments and an increase in business deals shaping the landscape for the industries. Public ...

The Parenteral Drug Association(PDA) will be celebrating 80 years of service to our members and the wider industry at PDA Week 2026. Since 1946 PDA has worked tirelessly to advance pharma ...

By freeing enzyme-driven chemical reactions from the limitations imposed by cells, exozyme biosolutions eliminate the scaling bottleneck that has hampered commercial success in the synthetic biology ...

When MEI Pharma announced it was considering its “strategic alternatives” in the wake of a failed merger last year, the options seemed pretty mundane. But, rather than winding down the company as the ...

Collegium Pharmaceutical Inc. (COLL) on Thursday reported fourth-quarter net income of $17 million. On a per-share basis, the ...

In today’s Pharmaceutical Executive Daily, Alkermes outlines its CEO succession plan following Richard Pops’ retirement announcement, leadership changes continue at Sarepta Therapeutics and Rivus ...